Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Water therapy for back pain? new study shows promise

NCT ID NCT06471998

Symptom relief Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new treatment called Localized Tissue Hydration for people with chronic low back pain. The treatment was added to standard care for 30 adults. The main goal was to see if it could reduce pain by at least 30% after 6 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

30 people

The number who actually took part.

Started

Feb 2025

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient 18 years of age or older ; * Patient with chronic, non-operated low-back pain operated for more than 3 months (verbal numerical scale ≥ 5); * Chronic common lumbago not requiring surgical management surgical ; * Lumbar MRI performed as part of routine care and available available for the inclusion visit; * For women of childbearing age, use of a highly effective contraceptive method; * Patient affiliated to a French health insurance scheme; * Patient has signed an informed consent form. Exclusion Criteria: * Pregnant or breast-feeding woman; * Patient in accident at work ; * Patient with radicular syndrome; * Contraindication to magnetic resonance imaging or CT scan; * Severe cases of hydric inflation and hydrosodic retention, particularly in cases of : * Decompensated heart failure; * Acute renal failure with oliguria or anuria; * Decompensated liver failure; * Pre-eclampsia/eclampsia. * Hypochloremia ; * Hypernatremia ; * Patients of legal age subject to legal protection, guardianship, curatorship or deprived of liberty by judicial or administrative decision; * Patient hospitalized without consent; * Patient unable to answer a questionnaire; * Patients who do not understand or speak French. Exclusion period for inclusion in another study : Included patients will not be allowed to participate in another interventional study during the entire follow-up period. The exclusion period is 8.5 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic low back pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic low back pain

Contacts and locations

Locations

  • Hôpital Privé Clairval

    Marseille, 13009, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.